Skip to main content
All lobbying filings

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $140,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 1
  • HR 5316
    Drug Shortage Compounding Patient Access Act of 2025
 Lobbying activity 3
Pharmacy

Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025

Medicare/Medicaid

Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees

Budget/Appropriations

Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem